Monday, May 25, 2015 | Latest E-book
You are here:
Pharma
#

Pharma

Articles

View all

Mid-cap pharma shares slide as investors book profit after recent upsurge

May 25, 2015

Mid-cap pharma shares slide as investors book profit after recent upsurge

The sector faces near-term headwinds such as a slower-than-expected pick up in the USFDA approvals and currency volatility #Sensex #Stock market #USFDA #mid-cap pharma stocks
Mid-cap pharma shares buck weak sentiment; Aurobindo, Wockhardt up nearly 3%

May 19, 2015

Mid-cap pharma shares buck weak sentiment; Aurobindo, Wockhardt up nearly 3%

Recovery in mid-cap pharma shares comes even as the benchmark Sensex and other key indices continue to linger in negative territory #Cadila #Wockhardt #Pharma #mid-cap stocks #Aurobindo
Sun Pharma maybe willing to shell out $7 bn on further acquisitions

Apr 28, 2015

Sun Pharma maybe willing to shell out $7 bn on further acquisitions

Sun Pharmaceuticals Industries, emboldened by its takeover of domestic rival Ranbaxy Laboratories, is willing to spend as much as $7 billion on further acquisitions, bankers familiar with the generic drugmaker's strategy said. #Sun Pharma #Ranbaxy #Dilip Shanghvi #drugmaker
Daiichi Sankyo's misery ends, block deal to give company coup de grce

Apr 22, 2015

Daiichi Sankyo's misery ends, block deal to give company coup de grce

Even after allowing for control premium, the price that Daiichi Sankyo paid for Ranbaxy Laboratories was clearly excessive, and those in the know said sagely that winners curse would have its say sooner than later. #Ranbaxy Laboratories #Sun Pharma #CompanyWatch #Daiichi Sankyo #Diageo #USFDA #United Spirits #Dilip Sanghvi

BLOG POSTS

View all

It's not just Ranbaxy, our health care regulators have failed us too

May 23, 2013

It's not just Ranbaxy, our health care regulators have failed us too

The Ranbaxy saga of fraud and greed goes beyond that. In India, it shows how our regulators too have failed us. #TheLongView #Health #Drugs #Ranbaxy #Healthcare #Pharma
Why a global fight against cancer is a good idea

Apr 10, 2013

Why a global fight against cancer is a good idea

In a substantive paper published today in the journal Nature Reviews, a group of authors from Singapore, the USA and Brazil evaluate the cost of cancer medication in low and middle income countries. #WhyNow #Cancer #Healthcare #Diabetes #Novartis #glivec #Merck #Dabur Pharma